Key facts
- It has raised $770K; the latest was Later Stage VC in Oct 2025.
- Notable investors include Tech Incubator Program for Startup, MedTech Innovator, Korea Investment Partners, Korea Technology Finance, Ministry of SMEs and Startups — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for VPIX Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for VPIX Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About VPIX Medical
Developer of a research instrument designed to enhance biological and medical research by providing a technology for in vivo imaging. The company's handheld microscope can be used during cancer surgery to visualize tumor tissues in real-time, enabling surgeons, pathologists, and other surgical team members to observe cancer cells clearly during an oncology surgery.
- Sector
- Healthcare
- HQ
- Daejeon, South Korea
- Founded
- 2016
- Employees
- 15
- Website
- vpixmedical.com/
- Ownership
- Privately Held (backing)
VPIX Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in VPIX Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on VPIX Medical in its N-PORT filings yet. We sweep new filings monthly.